This substance was first investigated pharmacologically and bacteriologically by Smith and Wiederkehrl who found, by in vitro testing, that various dilutions of tubercle bacilli, resistant to streptomycin and INH, were sensitive to GEWO 339; and they claimed further that its effectiveness in vivo exceeded that of a physical mixture of INH and PAS. In addition, it has been found that, under certain conditions, Dipasic may split to form free PAS and INH.** s Aufdermaur and Brodhage4 found that Dipasic restricted lymphogenous and hematogenous spread of the tubercle bacilli in guinea pigs and that it accelerated the healing process. The latter author2 suggested that the salt probably possessed a bacteriostatic effect of its own.
The clinical trials of Dipasic in patients with pulmonary tuberculosis showed favorable responses of varying degrees and revealed the presence of no allergic manifestation necessitating cessation of therapy with this d r~g .~-7
Of 17 patients included in a bacteriologic and clinical trial of Dipasic, three have experienced allergic responses to Dipasic. The severity of these reactions has required the discontinuance of Dipasic. Because only mild or transient reactions were noted by other workers using Dipasic, it was thought advisable to call attention to these reactions in patients who had such previous sensitivity. Each of the three patients were previously sensitive to para-aminosalicylic acid. 
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Because of recent positive gastric contents, increased cough and decreased appetite, he was placed on Dipasic 600 mgm. daily on May 11, 1956. After two days of Dipasic he developed generalized pruritus which progressed to a generalized rash with conjunctivitis. By June 22, 1956 these signs and symptoms had all but disappeared after stopping the Dipasic and treatment with benadryl 50 mgm. four times daily. Eventually all medications had to be stopped because of severe dermatitis which was thought to be due to streptomycin, PAS, and possibly INH. On May 14th, 1956
Dipasic 200 mgm. twice daily was substituted for the previously given anti-tubercr~losis drugs. On May 22nd the erythematous, severely pruritic dermatitis recurred and Dipasic was discontinued.
Case 3, No. 14285: C. U., a 48 year old furniture worker, was transferred from the Psychiatric Division on April 6, 1966 with the diagnosis of acute hallucinosis, because of a suspicious-looking x-ray film of the chest. With the history of chronic non-productive cough, 20 pound weight loss, post-tussive rales a t the left apex and a chest film showing soft mottling and increased densities throughout both upper lobes, it was felt that there was active pulmonary tuberculosis. Previous examinations by the Board of Health were considered to indicate arrested disease.
On April 12th, he was started on INH and PAS. On May seventh he developed fever, diarrhea and a morbilliform rash over his trunk and extremities. The PAS and INH were discontinued; he received pyribenzamine and by May 14, 1956 his rash and fever had subsided. On this date he was started on Dipasic 200 mgm. twice daily; six hours following his initial dose he experienced nausea, fever, malaise, headache, photophobia, conjunctivitis and had leukocytosis and eosinophilia. The Dipasic was discontinued, he again received pyribenzamine and by May 18, 1956 symptoms had subsided and skin lesions had disappeared.
